Loading...

LED Medical Diagnostics

OTCPK:LEDI.F
Snowflake Description

Mediocre balance sheet with questionable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
LEDI.F
OTCPK
CA$14M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

LED Medical Diagnostics Inc. develops and markets diagnostic dental imaging products and software in North America. The last earnings update was 50 days ago. More info.


Add to Portfolio Compare Print
LEDI.F Share Price and Events
7 Day Returns
-14.7%
OTCPK:LEDI.F
-0.9%
US Medical Equipment
0.6%
US Market
1 Year Returns
-4.4%
OTCPK:LEDI.F
13.5%
US Medical Equipment
4.1%
US Market
LEDI.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
LED Medical Diagnostics (LEDI.F) -14.7% -5.4% -0.4% -4.4% -68.6% -93.2%
US Medical Equipment -0.9% 2.4% 12.5% 13.5% 60.9% 101%
US Market 0.6% 3.8% 2.8% 4.1% 37.3% 42.5%
1 Year Return vs Industry and Market
  • LEDI.F underperformed the Medical Equipment industry which returned 13.5% over the past year.
  • LEDI.F underperformed the Market in United States of America which returned 4.1% over the past year.
Price Volatility
LEDI.F
Industry
5yr Volatility vs Market

LEDI.F Value

 Is LED Medical Diagnostics undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for LED Medical Diagnostics. This is due to cash flow or dividend data being unavailable. The share price is $0.267006.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for LED Medical Diagnostics's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are LED Medical Diagnostics's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:LEDI.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $0.00
TSXV:LMD Share Price ** TSXV (2019-07-17) in CAD CA$0.36
TSXV:LMD Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.766 $0.28
United States of America Medical Equipment Industry PE Ratio Median Figure of 64 Publicly-Listed Medical Equipment Companies 41.01x
United States of America Market PE Ratio Median Figure of 3,082 Publicly-Listed Companies 17.98x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of LED Medical Diagnostics.

OTCPK:LEDI.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSXV:LMD Share Price ÷ EPS (both in USD)

= 0.28 ÷ 0.00

82.56x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LED Medical Diagnostics is overvalued based on earnings compared to the US Medical Equipment industry average.
  • LED Medical Diagnostics is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does LED Medical Diagnostics's expected growth come at a high price?
Raw Data
OTCPK:LEDI.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 82.56x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Medical Equipment Industry PEG Ratio Median Figure of 55 Publicly-Listed Medical Equipment Companies 2.3x
United States of America Market PEG Ratio Median Figure of 2,122 Publicly-Listed Companies 1.59x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for LED Medical Diagnostics, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on LED Medical Diagnostics's assets?
Raw Data
OTCPK:LEDI.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $0.10
TSXV:LMD Share Price * TSXV (2019-07-17) in CAD CA$0.36
TSXV:LMD Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.766 $0.28
United States of America Medical Equipment Industry PB Ratio Median Figure of 183 Publicly-Listed Medical Equipment Companies 4.32x
United States of America Market PB Ratio Median Figure of 5,241 Publicly-Listed Companies 1.81x
OTCPK:LEDI.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSXV:LMD Share Price ÷ Book Value per Share (both in USD)

= 0.28 ÷ 0.10

2.67x

* Primary Listing of LED Medical Diagnostics.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LED Medical Diagnostics is good value based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess LED Medical Diagnostics's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. LED Medical Diagnostics has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

LEDI.F Future Performance

 How is LED Medical Diagnostics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LED Medical Diagnostics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
21.9%
Expected Medical Equipment industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is LED Medical Diagnostics expected to grow at an attractive rate?
  • Unable to compare LED Medical Diagnostics's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare LED Medical Diagnostics's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare LED Medical Diagnostics's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:LEDI.F Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.9%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.8%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.1%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:LEDI.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:LEDI.F Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
OTCPK:LEDI.F Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 15 -1 0
2018-12-31 14 -2 1
2018-09-30 14 -2 -1
2018-06-30 14 -3 -2
2018-03-31 14 -4 -1
2017-12-31 13 -4 -2
2017-09-30 11 -3 -3
2017-06-30 10 -3 -2
2017-03-31 10 -3 -4
2016-12-31 10 -2 -5
2016-09-30 14 -2 -5
2016-06-30 13 -3 -6

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if LED Medical Diagnostics is high growth as no earnings estimate data is available.
  • Unable to determine if LED Medical Diagnostics is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:LEDI.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from LED Medical Diagnostics Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:LEDI.F Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
OTCPK:LEDI.F Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 0.00
2018-12-31 0.02
2018-09-30 -0.02
2018-06-30 -0.05
2018-03-31 -0.04
2017-12-31 -0.08
2017-09-30 -0.11
2017-06-30 -0.11
2017-03-31 -0.30
2016-12-31 -0.47
2016-09-30 -0.48
2016-06-30 -0.55

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if LED Medical Diagnostics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of LEDI.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. LED Medical Diagnostics's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access LED Medical Diagnostics's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess LED Medical Diagnostics's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
LED Medical Diagnostics has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

LEDI.F Past Performance

  How has LED Medical Diagnostics performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare LED Medical Diagnostics's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • LED Medical Diagnostics has delivered over 20% year on year earnings growth in the past 5 years.
  • LED Medical Diagnostics has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • LED Medical Diagnostics has become profitable in the last year making it difficult to compare the US Medical Equipment industry average.
Earnings and Revenue History
LED Medical Diagnostics's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from LED Medical Diagnostics Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:LEDI.F Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 14.70 0.13 7.49 1.18
2018-12-31 14.22 0.82 7.63 1.16
2018-09-30 14.10 -0.59 8.28 1.20
2018-06-30 13.89 -1.86 8.14 1.20
2018-03-31 13.92 -1.33 8.33 1.18
2017-12-31 12.69 -2.50 7.98 1.04
2017-09-30 10.86 -3.01 6.60 0.73
2017-06-30 10.16 -2.42 6.41 0.47
2017-03-31 10.11 -4.41 6.30 0.24
2016-12-31 10.17 -5.37 7.11 0.13
2016-09-30 13.94 -5.11 8.15 0.15
2016-06-30 13.24 -5.62 8.43 0.15
2016-03-31 12.85 -5.74 8.54 0.19
2015-12-31 13.14 -5.18 8.24 0.19
2015-09-30 12.18 -4.73 8.02 0.18
2015-06-30 12.03 -6.06 8.83 0.26
2015-03-31 10.35 -4.78 9.10 0.29
2014-12-31 8.96 -6.18 8.49 0.50
2014-09-30 4.49 -6.97 7.36 0.59
2014-06-30 3.77 -6.23 5.63 0.60
2014-03-31 3.26 -8.52 4.10 0.61
2013-12-31 2.52 -6.96 3.99 0.44
2013-09-30 3.69 -5.67 3.55 0.42
2013-06-30 5.67 -2.96 3.70 0.41
2013-03-31 5.62 -0.95 3.90 0.44
2012-12-31 6.31 -0.87 3.77 0.52
2012-09-30 5.43 -3.69 4.50 0.58

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • LED Medical Diagnostics has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • LED Medical Diagnostics used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.
  • It is difficult to establish if LED Medical Diagnostics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess LED Medical Diagnostics's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
LED Medical Diagnostics has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

LEDI.F Health

 How is LED Medical Diagnostics's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up LED Medical Diagnostics's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • LED Medical Diagnostics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • LED Medical Diagnostics's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of LED Medical Diagnostics's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from LED Medical Diagnostics Company Filings, last reported 3 months ago.

OTCPK:LEDI.F Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 4.01 7.86 2.54
2018-12-31 4.09 7.96 2.83
2018-09-30 3.48 9.11 3.41
2018-06-30 3.47 6.14 1.17
2018-03-31 2.98 5.90 1.43
2017-12-31 2.82 5.87 2.43
2017-09-30 3.92 3.84 1.12
2017-06-30 5.27 3.62 1.51
2017-03-31 4.15 3.39 2.91
2016-12-31 -3.89 2.62 0.87
2016-09-30 -2.60 1.52 0.34
2016-06-30 -1.74 1.25 0.36
2016-03-31 -0.70 1.25 1.18
2015-12-31 1.15 1.25 1.99
2015-09-30 0.74 1.28 1.17
2015-06-30 2.06 0.00 1.46
2015-03-31 2.96 0.00 1.11
2014-12-31 2.17 0.00 2.40
2014-09-30 2.96 0.00 0.82
2014-06-30 0.31 0.00 1.84
2014-03-31 -1.43 0.00 3.18
2013-12-31 0.86 0.00 4.36
2013-09-30 -3.14 0.00 0.97
2013-06-30 -1.22 0.00 1.72
2013-03-31 -1.11 0.00 0.61
2012-12-31 -0.13 0.00 0.97
2012-09-30 0.22 0.00 0.39
  • LED Medical Diagnostics's level of debt (196.3%) compared to net worth is high (greater than 40%).
  • LED Medical Diagnostics had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on LED Medical Diagnostics's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess LED Medical Diagnostics's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. LED Medical Diagnostics has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

LEDI.F Dividends

 What is LED Medical Diagnostics's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from LED Medical Diagnostics dividends.
If you bought $2,000 of LED Medical Diagnostics shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate LED Medical Diagnostics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate LED Medical Diagnostics's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:LEDI.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2017 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:LEDI.F Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as LED Medical Diagnostics has not reported any payouts.
  • Unable to verify if LED Medical Diagnostics's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of LED Medical Diagnostics's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as LED Medical Diagnostics has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess LED Medical Diagnostics's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can LED Medical Diagnostics afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. LED Medical Diagnostics has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

LEDI.F Management

 What is the CEO of LED Medical Diagnostics's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
David Gane
COMPENSATION $295,498
TENURE AS CEO 5.8 years
CEO Bio

Dr. David Gane, DDS, has been the Chief Executive Officer of LED Medical Diagnostics, Inc. since October 10, 2013. Dr. Gane serves as Program Director, Imaging Technologies for Experdent Centers of Dental Excellence. He is a passionate pioneer in the business having founded Orbit Imaging, a company that owns and operates Craniofacial imaging centers in Western Canada. He is a dental surgeon. He served as and President of LED Medical Diagnostics, Inc. since October 4, 2013. Dr. Gane served as Chief Executive Officer, President, Secretary and Treasurer of Reality Wireless Networks Inc. until November 21, 2001. He was an Officer of Dicom Imaging Systems since March 17, 1999. Dr. Gane served as the President and Co-Founder of Source Dental Image Inc. from March of 1992 to January of 1995. Dr. Gane served as Vice President of Dental Imaging, for Carestream Dental LLC. He was a Co-Founder of Image FX Software Solutions Inc. from February 1995 to February 1999, a company specializing in the development and sales of Imaging Solutions to Dentists and Physicians. Dr. Gane has consulted for a number of Corporations and Universities on matters related to dental imaging. He has been a Director of LED Medical Diagnostics, Inc. since August 28, 2014. He served as a Director of Dicom Imaging Systems since March 17, 1999. He served as Director of American Petro-hunter Inc. until June 1999 and Reality Wireless Networks Inc. until November 21, 2001. He has also lectured worldwide and published on the topic of dental imaging and cosmetic dentistry. Dr. Gane has practiced dentistry since June of 1981 and maintains an exclusive part time dental practice limited to advanced restorative dentistry. He is a member of the Canadian Dental Association, the American Dental Association and the American Academy of Oral and Maxillofacial Radiology, where he served as Chairman of the Corporate Liaison Committee. He has authored a number of dental imaging software applications, co-authored a number of peer reviewed academic articles, as well as a series of technique videos on digital dental imaging. Dr. Gane graduated from the University of Western Ontario in 1977, (B.Sc. Honors), and in 1981 with his Doctorate in Dental Surgery (D.D.S.).

CEO Compensation
  • David's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Insufficient data for David to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure of the LED Medical Diagnostics management team in years:

5.4
Average Tenure
  • The average tenure for the LED Medical Diagnostics management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

David Gane

TITLE
President
COMPENSATION
$295K
TENURE
5.8 yrs

Lamar Roberts

TITLE
President of LED Dental
COMPENSATION
$249K
TENURE
5.4 yrs

Peter Whitehead

TITLE
Consultant
COMPENSATION
$517K
AGE
50
TENURE
4.8 yrs
Board of Directors Tenure

Average tenure of the LED Medical Diagnostics board of directors in years:

1.2
Average Tenure
  • The average tenure for the LED Medical Diagnostics board of directors is less than 3 years, this suggests a new board.
Board of Directors

Darryl Yea

TITLE
Chairman of the Board
COMPENSATION
$38K
AGE
60
TENURE
4.8 yrs

David Gane

TITLE
President
COMPENSATION
$295K
TENURE
4.9 yrs

George Reznik

TITLE
Director
AGE
52
TENURE
0.1 yrs

Joel Leetzow

TITLE
Director
COMPENSATION
$7K
TENURE
1.9 yrs

Alex Ryzhikov

TITLE
Director
TENURE
0.5 yrs

Lou Shuman

TITLE
Director
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess LED Medical Diagnostics's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. LED Medical Diagnostics has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

LEDI.F News

Simply Wall St News

LEDI.F Company Info

Description

LED Medical Diagnostics Inc. develops and markets diagnostic dental imaging products and software in North America. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and VELscope and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides XrayVision DICOM Capture View (DCV), a dental imaging suite to capture, storage, retrieve, and view images across an entire organization; XV4 Mobile for patient follow-up and emergency use in the operating room, remote or mobile clinic, or at home; XVWeb, a Web application that allows an organization to view their images from various Web-enabled devices; and XrayVision, an open-architecture digital image management program. In addition, it offers XV Sync that enables automatic synchronization of various databases for a dental practice; DataGrabber, which allows a customer to bridge patient information from various patient management software packages to a customer’s digital imaging software; DCV Data Manager, a picture archive and communication system server application; and XVLite, an open architecture digital dental x-ray software package for capturing, enhancing, and displaying dental images. Further, the company provides data mapping and database conversion services; intraoral digital radiographic sensors under the Tuxedo name; intraoral cameras; and 3D imagining hardware products under the RAYSCAN name. It serves dentists and oral health specialists. LED Medical Diagnostics Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Details
Name: LED Medical Diagnostics Inc.
LEDI.F
Exchange: OTCPK
Founded: 2002
CA$10,697,943
38,785,096
Website: http://ledapteryx.com
Address: LED Medical Diagnostics Inc.
580 Hornby Street,
Unit 810,
Vancouver,
British Columbia, V6C 3B6,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSXV LMD Common Shares TSX Venture Exchange CA CAD 28. Nov 2011
OTCPK LEDI.F Common Shares Pink Sheets LLC US USD 28. Nov 2011
DB LME1 Common Shares Deutsche Boerse AG DE EUR 28. Nov 2011
Number of employees
Current staff
Staff numbers
46
LED Medical Diagnostics employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/18 00:30
End of day share price update: 2019/07/17 00:00
Last estimates confirmation: 2017/04/28
Last earnings filing: 2019/05/29
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.